Cronos Group Inc. (CRON)
NASDAQ: CRON · Real-Time Price · USD
2.010
-0.020 (-0.99%)
At close: Nov 20, 2024, 4:00 PM
2.020
+0.010 (0.50%)
Pre-market: Nov 21, 2024, 7:10 AM EST
Cronos Group Revenue
Cronos Group had revenue of $34.26M in the quarter ending September 30, 2024, with 38.11% growth. This brings the company's revenue in the last twelve months to $111.23M, up 30.31% year-over-year. In the year 2023, Cronos Group had annual revenue of $87.24M with 0.57% growth.
Revenue (ttm)
$111.23M
Revenue Growth
+30.31%
P/S Ratio
n/a
Revenue / Employee
$312,441
Employees
356
Market Cap
761.60M
Revenue Chart
Revenue History
Fiscal Year End | Revenue | Change | Growth |
---|---|---|---|
Dec 31, 2023 | 87.24M | 492.00K | 0.57% |
Dec 31, 2022 | 86.75M | 22.19M | 34.37% |
Dec 31, 2021 | 64.56M | 17.84M | 38.19% |
Dec 31, 2020 | 46.72M | 22.97M | 96.71% |
Dec 31, 2019 | 23.75M | 11.63M | 95.94% |
Dec 31, 2018 | Pro | Pro | Pro |
Dec 31, 2017 | Pro | Pro | Pro |
Dec 31, 2016 | Pro | Pro | Pro |
Dec 31, 2015 | Pro | Pro | Pro |
Dec 31, 2014 | Pro | Pro | Pro |
Sources: Historical revenue is based on company filings submitted to the U.S. Securities and Exchange Commission (SEC). The most recent revenue numbers may be taken from company press releases.
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
Company Name | Revenue |
---|---|
Pacira BioSciences | 694.96M |
Avanos Medical | 681.50M |
Castle Biosciences | 311.88M |
Evolus | 248.33M |
Cytek Biosciences | 201.21M |
Avid Bioservices | 142.36M |
AbCellera Biologics | 32.96M |
CRON News
- 6 days ago - Gaetz as Trump's AG seen as bullish for pot stocks, but confirmation looks unlikely - Market Watch
- 8 days ago - Cannabis stock valuations and investments hobbled by regulatory uncertainties, experts say - Market Watch
- 8 days ago - Cronos Group Inc. (CRON) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 13 days ago - Cannabis stocks plunge after DeSantis, Griffin win Florida fight against weed legalization - New York Post
- 14 days ago - Cannabis Stocks Collapse After Trump Win: Major Players See Double-Digit Declines At Wednesday's Close - Benzinga
- 14 days ago - Cannabis stocks crater as Florida fails to garner needed votes for adult use - Market Watch
- 15 days ago - Top Canadian Cannabis Stocks to Track as U.S. Legalization Heats Up - MarijuanaStocks
- 22 days ago - Cronos Group Inc. to Hold 2024 Third Quarter Earnings Conference Call on November 12, 2024 - GlobeNewsWire